SCHEMBL10051209

SCHEMBL10051209

c1ccc(-c2cc(-c3ccc4ccc5cccc6ccc3c4c56)nc(-c3ccc(-c4ccc(-c5nc(-c6ccccc6)cc(-c6ccc7ccc8cccc9ccc6c7c89)n5)cc4)cc3)n2)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.49
KMT2A Q03164 8/20 0.49
HPGD P15428 8/20 0.49
ALDH1A1 P00352 7/20 0.49
MAPT P10636 6/20 0.49
NTSR1 P30989 1/20 0.49
KDM4E B2RXH2 4/20 0.47
LMNA P02545 2/20 0.47
GLA P06280 1/20 0.47
ADORA2A P29274 2/20 0.42
ADORA1 P30542 2/20 0.42
CYP1A1 P04798 1/20 0.42
CYP1B1 Q16678 1/20 0.42
NPSR1 Q6W5P4 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAOA P21397 4/20 0.40
ERBB2 P04626 1/20 0.40
CYP1A2 P05177 1/20 0.40
FYN P06241 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10051308 1.00 MEN1 (0.49) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19168116 0.93 MAPT (0.48) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19166989 0.93 MAPT (0.48) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19167643 0.93 MAPT (0.48) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19168485 0.93 MEN1 (0.50) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL13682539 0.92 ALDH1A1 (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL13682543 0.92 ALDH1A1 (0.42) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19168118 0.91 ATM (0.41) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL19166295 0.91 ATM (0.41) MEN1KMT2AHPGDALDH1A1MAPT
SCHEMBL13682548 0.90 CA12 (0.41) MEN1KMT2AHPGDALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2012-05-03 US disclosed
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME CHEIL INDUSTRIES, INC. (KR) 2012-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120104941-A1 COMPOUND FOR AN ORGANIC PHOTOELECTRIC DEVICE AND ORGANIC PHOTOELECTRIC DEVICE INCLUDING THE SAME PPOX, TYR, VDAC3 MEN1 3545/4885KMT2A 746/4885HPGD 1115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.